Annual CFF
$118.04 M
+$116.75 M+9093.07%
31 December 2023
Summary:
Editas Medicine annual cash flow from financing activities is currently $118.04 million, with the most recent change of +$116.75 million (+9093.07%) on 31 December 2023. During the last 3 years, it has fallen by -$106.08 million (-47.33%). EDIT annual CFF is now -58.16% below its all-time high of $282.11 million, reached on 31 December 2021.EDIT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$322.00 K-100.00%
30 September 2024
Summary:
Editas Medicine quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$322.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has stayed the same.EDIT quarterly CFF is now -100.00% below its all-time high of $261.47 million, reached on 31 March 2021.EDIT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.03 M
$0.000.00%
30 September 2024
Summary:
Editas Medicine TTM cash flow from financing activities is currently $1.03 million, unchanged on 30 September 2024. Over the past year, it has dropped by -$117.12 million (-99.13%). EDIT TTM CFF is now -99.79% below its all-time high of $482.55 million, reached on 31 March 2021.EDIT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9093.1% | 0.0% | -99.1% |
| 3 y3 years | -47.3% | -100.0% | -99.7% |
| 5 y5 years | +35.8% | -100.0% | -98.7% |
EDIT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.2% | +9093.1% | -100.0% | -99.7% | at low | |
| 5 y | 5 years | -58.2% | +9093.1% | -100.0% | -99.8% | at low | |
| alltime | all time | -58.2% | +9093.1% | -100.0% | +100.0% | -99.8% | +30.0% |
Editas Medicine Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $1.03 M(0.0%) |
| June 2024 | - | $322.00 K(+67.7%) | $1.03 M(-99.1%) |
| Mar 2024 | - | $192.00 K(-62.6%) | $118.23 M(+0.2%) |
| Dec 2023 | $118.04 M(+9093.1%) | $514.00 K(>+9900.0%) | $118.04 M(-0.1%) |
| Sept 2023 | - | $0.00(-100.0%) | $118.14 M(-0.1%) |
| June 2023 | - | $117.53 M(>+9900.0%) | $118.22 M(>+9900.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $1.07 M(-17.0%) |
| Dec 2022 | $1.28 M(-99.5%) | $619.00 K(+673.8%) | $1.28 M(-25.4%) |
| Sept 2022 | - | $80.00 K(-78.2%) | $1.72 M(-58.4%) |
| June 2022 | - | $367.00 K(+68.3%) | $4.14 M(-80.2%) |
| Mar 2022 | - | $218.00 K(-79.4%) | $20.85 M(-92.6%) |
| Dec 2021 | $282.11 M(+25.9%) | $1.06 M(-57.7%) | $282.11 M(-2.8%) |
| Sept 2021 | - | $2.50 M(-85.4%) | $290.15 M(+0.6%) |
| June 2021 | - | $17.08 M(-93.5%) | $288.48 M(-40.2%) |
| Mar 2021 | - | $261.47 M(+2773.3%) | $482.55 M(+115.3%) |
| Dec 2020 | $224.12 M(+70.0%) | $9.10 M(+1007.1%) | $224.12 M(-25.2%) |
| Sept 2020 | - | $822.00 K(-99.6%) | $299.59 M(-12.4%) |
| June 2020 | - | $211.15 M(+6829.9%) | $342.12 M(+156.6%) |
| Mar 2020 | - | $3.05 M(-96.4%) | $133.34 M(+1.1%) |
| Dec 2019 | $131.82 M | $84.57 M(+95.1%) | $131.82 M(+69.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $43.35 M(+1730.0%) | $77.61 M(+118.6%) |
| June 2019 | - | $2.37 M(+54.5%) | $35.49 M(-0.8%) |
| Mar 2019 | - | $1.53 M(-94.9%) | $35.79 M(-58.8%) |
| Dec 2018 | $86.94 M(-43.7%) | $30.35 M(+2347.7%) | $86.94 M(-24.4%) |
| Sept 2018 | - | $1.24 M(-53.5%) | $115.07 M(+1.7%) |
| June 2018 | - | $2.67 M(-94.9%) | $113.10 M(+2.7%) |
| Mar 2018 | - | $52.68 M(-9.9%) | $110.12 M(-28.7%) |
| Dec 2017 | $154.53 M(+59.0%) | $58.48 M(-8110.8%) | $154.53 M(+61.8%) |
| Sept 2017 | - | -$730.00 K(+136.2%) | $95.52 M(-0.7%) |
| June 2017 | - | -$309.00 K(-100.3%) | $96.22 M(+0.2%) |
| Mar 2017 | - | $97.09 M(<-9900.0%) | $96.04 M(-1.2%) |
| Dec 2016 | $97.16 M(-30.3%) | -$538.00 K(+2345.5%) | $97.16 M(+3.4%) |
| Sept 2016 | - | -$22.00 K(-95.5%) | $93.95 M(-56.2%) |
| June 2016 | - | -$494.00 K(-100.5%) | $214.36 M(-9.5%) |
| Mar 2016 | - | $98.22 M(-2717.7%) | $236.81 M(+69.9%) |
| Dec 2015 | $139.39 M(+654.2%) | -$3.75 M(-103.1%) | $139.39 M(-2.6%) |
| Sept 2015 | - | $120.39 M(+448.2%) | $143.14 M(+529.1%) |
| June 2015 | - | $21.96 M(+2676.4%) | $22.75 M(+2776.4%) |
| Mar 2015 | - | $791.00 K | $791.00 K |
| Dec 2014 | $18.48 M | - | - |
FAQ
- What is Editas Medicine annual cash flow from financing activities?
- What is the all time high annual CFF for Editas Medicine?
- What is Editas Medicine annual CFF year-on-year change?
- What is Editas Medicine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Editas Medicine?
- What is Editas Medicine quarterly CFF year-on-year change?
- What is Editas Medicine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Editas Medicine?
- What is Editas Medicine TTM CFF year-on-year change?
What is Editas Medicine annual cash flow from financing activities?
The current annual CFF of EDIT is $118.04 M
What is the all time high annual CFF for Editas Medicine?
Editas Medicine all-time high annual cash flow from financing activities is $282.11 M
What is Editas Medicine annual CFF year-on-year change?
Over the past year, EDIT annual cash flow from financing activities has changed by +$116.75 M (+9093.07%)
What is Editas Medicine quarterly cash flow from financing activities?
The current quarterly CFF of EDIT is $0.00
What is the all time high quarterly CFF for Editas Medicine?
Editas Medicine all-time high quarterly cash flow from financing activities is $261.47 M
What is Editas Medicine quarterly CFF year-on-year change?
Over the past year, EDIT quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Editas Medicine TTM cash flow from financing activities?
The current TTM CFF of EDIT is $1.03 M
What is the all time high TTM CFF for Editas Medicine?
Editas Medicine all-time high TTM cash flow from financing activities is $482.55 M
What is Editas Medicine TTM CFF year-on-year change?
Over the past year, EDIT TTM cash flow from financing activities has changed by -$117.12 M (-99.13%)